PRO131921
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PRO131921, covering 2013-01-28 to 2017-07-02. Get the full timeline:
Most recent: Clinical Trial Update: A Trial of the Safety of Escalating Doses of PRO131921 in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia [Phase 1, Phase 2]